Human Genome Sciences Inc. has a market cap of $4.68 billion; its shares were traded at around $24.82 with and P/S ratio of 17.
HGSI is in the portfolios of Steven Cohen of SAC Capital Advisors, Andreas Halvorsen of Viking Global Investors LP, Columbia Wanger of Columbia Wanger Asset Management, Bruce Kovner of Caxton Associates, RS Investment Management, Louis Moore Bacon of Moore Capital Management, LP.
This is the insider trade history vs. stock price of HGSI. For the complete insider trading history of HGSI, click here.
Directors and Officers Recent Trades:
- Sell: Sr. VP, Operations Curran Simpson sold 22,903 shares of HGSI stock on 10/01/2010 at the average price of 29.79. Curran Simpson owns at least 25,281 shares after this. The price of the stock has decreased by 16.68% since.
- Sell: Exec. VP, Gen Counsel & Sec. James H Davis sold 26,000 shares of HGSI stock on 09/20/2010 at the average price of 30.01. James H Davis owns at least 88,739 shares after this. The price of the stock has decreased by 17.29% since.
- Sell: Exec VP & CCO Barry Labinger sold 50,000 shares of HGSI stock on 09/01/2010 at the average price of 30.02. The price of the stock has decreased by 17.32% since.
- Sell: Exec VP & CCO Barry Labinger sold 29,129 shares of HGSI stock on 08/27/2010 at the average price of 28.52. The price of the stock has decreased by 12.97% since.
- Sell: Sr. VP, Operations Curran Simpson sold 18,461 shares of HGSI stock on 08/25/2010 at the average price of 28. Curran Simpson owns at least 25,281 shares after this. The price of the stock has decreased by 11.36% since.






RSS